Net improvement in intervention and control groups at 6 months
| Intervention group | Control group | Difference in net %better (95% CI)* | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Total | No. better | No. worse | Net %better | Total | No. better | No. worse | Net %better | ||
| *Difference = value in intervention group minus value in control group. | |||||||||
| †Perceived change in medication use in last 6 months compared with use before then. | |||||||||
| For medication, preventers and relievers, “better” and “worse” denote less and more use respectively. | |||||||||
| Breathing since baseline | 67 | 39 | 4 | 52 | 58 | 12 | 12 | 0 | 52 (30 to 74) |
| Medication in last 6 months† | 66 | 36 | 9 | 41 | 59 | 7 | 17 | −17 | 59 (35 to 81) |
| Preventer in last 4 weeks | 67 | 18 | 6 | 18 | 61 | 6 | 7 | −2 | 20 (2 to 37) |
| Reliever in last 4 weeks | 67 | 10 | 3 | 10 | 61 | 8 | 3 | 8 | 2 (−12 to 17) |
| Wheeze in last 4 weeks | 67 | 15 | 7 | 12 | 61 | 7 | 5 | 3 | 9 (−9 to 26) |
| Wheeze disturbs sleep | 67 | 25 | 6 | 28 | 61 | 19 | 11 | 13 | 15 (−7 to 38) |
| Wheeze limits speech | 65 | 13 | 1 | 19 | 61 | 7 | 3 | 7 | 12 (−2 to 26) |
| Wheeze affects activities | 67 | 27 | 6 | 31 | 61 | 15 | 11 | 7 | 25 (3 to 47) |
| Rhinitis | 65 | 15 | 7 | 12 | 61 | 9 | 6 | 5 | 7 (−11 to 26) |
| Rhinoconjunctivitis | 65 | 15 | 8 | 11 | 61 | 6 | 9 | −5 | 16 (−3 to 35) |
| Rhinitis affects activities | 65 | 16 | 10 | 9 | 61 | 18 | 12 | 10 | −1 (−23 to 22) |